NCT07463235 2026-03-13
SPARAGMOS
University of Sao Paulo General Hospital
Phase 3 Recruiting
Clinical Trials
9 trialsNCT07168837 2025-09-11
Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction
Al-Azhar University
Phase NA Completed
NCT07034859 2025-06-24
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
National Taiwan University Hospital
Phase 4 Enrolling by invitation
NCT03457389 2020-03-18
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
Phase NA Unknown
NCT01730729 2019-09-17
Cabergoline in Metastatic Breast Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
NCT03271918 2017-09-07
Cabergoline in Nonfunctioning Pituitary Adenomas
University of Sao Paulo General Hospital
Phase 3 Completed
NCT01620138 2016-08-22
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
Universidade Federal do Rio de Janeiro
Phase 2/3 Completed
NCT01569256 2012-04-04
Ovarian Hyperstimulation Syndrome and Cabergoline
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Phase NA Completed
NCT00889525 2009-04-29
Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Seth Gordhandas Sunderdas Medical College
Phase 3 Completed